9AVA
A1AG1: (2R)-2-[(5R,6S,8R,9aS)-8-amino-1-oxo-5-(2-phenylethyl)hexahydro-1H-pyrrolo[1,2-a][1,4]diazepin-2(3H)-yl]-N-[(3,4-dichlorophenyl)methyl]-4-methylpentanamide
A1AG1 is a Ligand Of Interest in 9AVA designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9AVA_A1AG1_K_302 | 80% | 81% | 0.104 | 0.952 | 0.32 | 0.49 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_B_302 | 79% | 85% | 0.104 | 0.949 | 0.39 | 0.36 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_F_302 | 79% | 86% | 0.11 | 0.955 | 0.4 | 0.32 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_H_302 | 77% | 84% | 0.12 | 0.96 | 0.38 | 0.38 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_A_302 | 74% | 84% | 0.117 | 0.948 | 0.31 | 0.45 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_C_302 | 73% | 88% | 0.114 | 0.942 | 0.35 | 0.32 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_D_302 | 69% | 85% | 0.125 | 0.939 | 0.34 | 0.41 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_I_302 | 67% | 88% | 0.126 | 0.934 | 0.34 | 0.34 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_G_302 | 66% | 83% | 0.128 | 0.934 | 0.33 | 0.44 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_L_302 | 62% | 85% | 0.13 | 0.923 | 0.27 | 0.46 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_J_302 | 60% | 80% | 0.133 | 0.918 | 0.33 | 0.5 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_E_301 | 24% | 85% | 0.207 | 0.836 | 0.33 | 0.4 | - | - | 0 | 0 | 100% | 1 |
